| Frequency |
Sex | |
 Male | 14 |
 Female | 14 |
Genotype | |
 Deletion | 15 |
 Non-deletion | 13 |
  Paternal uniparental disomy (UPD) | 7 |
  Imprinting center defect (ICD) | 1 |
  UBE3A mutation | 5 |
Epilepsy | |
 Yes | 22 |
  Yes, active | 16 |
  Yes, controlled with anti-seizure medication | 6 |
 No | 6 |
  No, never | 4 |
  In remission (currently no anti-seizure medication) | 2 |
Socio-economic statusa | |
 Low-level educationb | 1 |
 Middle-level educationc | 16 |
 High-level educationd | 11 |
Comorbid psychiatric diagnoses | |
 No psychiatric diagnosis | 21 |
 Attention deficit hyperactivity disorder (ADHD) | 6 |
 Autism spectrum disorder (ASD) | 1 |
Medication use | |
 Antiseizure medication | |
  Valproic acid | 13 |
  Clobazam | 10 |
  Levetiracetam | 6 |
  Topiramate | 3 |
  Diazepam, lamotrigin, or ethosuximide | 2 |
  Ethosuximide, gabapentine, clonazepam, lacosamide, brivaracetam, or rufinamide | 1 |
 Psychotropic medication | |
  Methylphenidate | 4 |
  Risperidone | 2 |
  Aripiprazol | 1 |
 No medication | 5 |
Vision (as reported by parents) | |
 Normal vision | 9 |
 Farsightede | 9 |
 Strabismus | 8 |
 No stereovision | 5 |
 Nearsightede | 4 |
 Nystagmus | 2 |
Walking abilities | |
 Walking independently | 18 |
 Walking with support | 7 |
 Wheelchair dependent | 3 |
 | Mean (SD) |
Age | 11.04 (4.51) |
CGI-S scoref | |
 Total | 4.68 (0.78) |
 Behavior | 4.00 (0.98) |
 Motor (fine/gross) | 4.68 (0.61)/4.29 (1.33) |
 Communication (expressive/receptive) | 4.93 (1.05)/3.50 (1.17) |
 Sleep | 3.46 (1.64) |
PEDI-CAT scaled scores (N = 20)g | |
 Daily activities | 47.58 (4.17) |
 Mobility | 58.26 (5.28) |
 Social/cognitive | 53.89 (4.62) |